查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426466

2024 年染色质免疫沉淀 (ChIP)定序全球市场报告

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

染色质免疫沉淀（ChIP）定序的市场规模预计在未来几年将快速成长。预计到 2028 年将以 12.5% 的复合年增长率 (CAGR) 增长至 222.6 亿美元。预测期内的预期成长是由产业投资和竞争增加、诊断应用的临床采用增加、生物标誌物发现的需求、生物资讯工具的快速发展以及使用染色质免疫沉淀(ChIP) 定序的染色质免疫沉淀(ChIP)定序的。可能是由于药物发现应用的扩展。预测期内预计的主要趋势包括 ChIP定序在临床和诊断应用中的应用、对组蛋白修饰的更多关注、在新研究领域的应用、样品製备技术的进步以及多组体学的发展。例子包括整合。

染色质免疫沉淀 (ChIP)定序市场的成长预计将受到摄护腺癌盛行率不断上升的推动。发生在前列腺中的前列腺癌预计将有助于市场扩张。 ChIP-seq 透过提供对影响前列腺癌的分子事件的全面了解，在前列腺癌研究中发挥重要作用。这些资讯对于增进我们对其生物学的理解和开发更有针对性的治疗性介入至关重要。 2023年1月，美国癌症协会报告称，美国估计有288,300例前列腺癌新病例和34,700例死亡，ChIP-我们强调了seq的重要性。

个人化医疗的日益普及预计将推动染色质免疫沉淀 (ChIP)定序市场的成长。个人化医疗根据个别患者的特征量身订做医疗决策，并依赖识别与疾病相关的特定遗传或磊晶标记。 ChIP 定序已被证明是绘製磊晶修饰图谱的强大工具，这对于了解疾病的遗传基础非常重要。 2022年，FDA药物评估与研究中心核准了37个新分子实体，其中34%被个人化医疗联盟指定用于个人化医疗，以及染色质免疫沉淀（ChIP）定序在个人化医疗进展中的作用。该定序的突出显示。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球染色质免疫沉淀 (ChIP)定序市场，按类型细分、实际和预测，2018-2023、2023-2028、2033
  • 脱氧核糖核酸酶序列
  • 公平序列
  • 全球染色质免疫沉淀 (ChIP)定序市场，按技术、性能和预测细分，2018-2023、2023-2028、2033
  • 标靶定序和定序
  • 全基因组定序和全EXOME定序
  • 全球染色质免疫沉淀 (ChIP)定序市场，依工作流程、效能和预测细分，2018-2023、2023-2028、2033
  • 前序
  • 顺序
  • 资料分析
  • 全球染色质免疫沉淀 (ChIP)定序市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 耗材和试剂
  • 服务
  • 其他用途
  • 全球染色质免疫沉淀 (ChIP)定序市场，依最终用户细分、性能和预测，2018-2023、2023-2028、2033
  • 学术研究所
  • 临床研究所
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球染色质免疫沉淀 (ChIP)定序市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球染色质免疫沉淀 (ChIP)定序市场，按国家/地区、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 染色质免疫沉淀（ChIP）定序市场的竞争形势
  • 染色质免疫沉淀（ChIP）定序市场公司概况
    • F. Hoffmann La Roche Ltd.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Becton Dickinson and Co.
    • Eurofins Scientific SE

第31章 其他大型创新公司

  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Bio-Techne Corp.
  • BGI Genomics Co. Ltd.
  • Promega Corporation
  • GenScript Biotech Corporation
  • Abcam plc
  • BioLegend Inc.
  • Hamilton Co.
  • Takara Bio Inc.
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies plc

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13478

Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique employed to investigate the interactions between proteins and DNA within a cell, offering insights into the binding patterns of specific proteins, often transcription factors or other chromatin-associated proteins, to DNA in a genome-wide manner.

The main types of ChIP sequencing include DNase-sequencing and Faire-sequencing. DNase-sequencing, commonly known as DNase-seq, is a molecular biology technique designed to assess the accessibility of DNA within the genome. It utilizes various technologies such as targeted sequencing, re-sequencing, whole genome sequencing, and whole exome sequencing for pre-sequencing, sequencing, and data analysis. The applications of DNase-seq encompass consumables and reagents, services, and other related components. The technique finds usage in academic research institutes, clinical research institutes, hospitals and clinics, pharmaceuticals and biotechnology companies, among others.

The chromatin immunoprecipitation (ChIP) sequencing market research report is one of a series of new reports from The Business Research Company that provides chromatin immunoprecipitation (ChIP) sequencing market statistics, including chromatin immunoprecipitation (ChIP) sequencing industry global market size, regional shares, competitors with a chromatin immunoprecipitation (ChIP) sequencing market share, detailed chromatin immunoprecipitation (ChIP) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the chromatin immunoprecipitation (ChIP) sequencing industry. This chromatin immunoprecipitation (ChIP) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chip sequencing market size has grown rapidly in recent years. It will grow from $12.36 billion in 2023 to $13.89 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed during the historical period can be attributed to advancements in understanding gene regulation, a rise in epigenetics studies, improvements in data analysis and bioinformatics tools, and the associated cost reduction and scalability in Chromatin Immunoprecipitation (ChIP) sequencing techniques.

The chip sequencing market size is expected to see rapid growth in the next few years. It will grow to $22.26 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to increased industry investment and competition, growing clinical adoption for diagnostic applications, a demand for biomarker discovery, rapid development in bioinformatics tools, and expanded applications in drug discovery using Chromatin Immunoprecipitation (ChIP) sequencing. Major trends expected during the forecast period include the translation of ChIP sequencing into clinical and diagnostic applications, a heightened focus on histone modifications, application in novel research areas, advancements in sample preparation techniques, and the integration of multi-omics approaches.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be driven by the increasing prevalence of prostate cancer. Prostate cancer, which originates in the prostate gland, is anticipated to contribute to the market's expansion. ChIP-seq plays a vital role in prostate cancer research by providing a comprehensive understanding of the molecular events influencing the disease. This information is crucial for advancing the understanding of its biology and developing more targeted therapeutic interventions. In January 2023, the American Cancer Society reported an estimated 288,300 new cases of prostate cancer and 34,700 deaths in the US, emphasizing the significance of ChIP-seq in addressing this health concern.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be propelled by the increasing adoption of personalized medicine. Personalized medicine, which tailors medical decisions to individual patient characteristics, relies on identifying specific genetic or epigenetic markers associated with diseases. ChIP sequencing proves to be a powerful tool in mapping epigenetic modifications crucial for understanding the genetic basis of diseases. In 2022, the approval of 37 novel molecular entities by the FDA's Center for Drug Evaluation and Research, with 34% designated as tailored medications by the Personalized Medicine Coalition, highlights the role of ChIP sequencing in advancing personalized medicine.

The high cost of ChIP-sequencing technology is anticipated to hinder market growth. The substantial expenses associated with ChIP-Seq experiments, approximately $550 per sample, may limit the number of samples processed, slowing down research progress. This cost factor may impede the technology's adoption in therapeutic settings where cost-effectiveness is a critical consideration. While ChIP-Seq is considered more cost-effective than alternative methods, its expense, influenced by factors such as genome size and sequencing depth, remains a limiting factor for broader implementation.

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are addressing consumer needs through innovative products, such as molecular electronics chips. These chips, utilizing single molecules or molecular assemblies for electronic functions, aim to enhance research capabilities. For instance, Roswell Biotechnologies launched the Roswell ME Chip in November 2021, offering a flexible and potent tool for examining oligos and biological dynamics related to DNA and polymerase binding. This chip's potential applications extend across various industries, including fundamental science, environmental monitoring, and healthcare.

In August 2021, ProPhase Labs Inc., a US-based biotechnology company, acquired Nebula Genomics for $14.6 million. This strategic acquisition aligns with ProPhase's goal to better support individuals seeking assistance in diagnosing genetically impacted conditions. Nebula Genomics, known for its web service analyzing ChIP-sequencing (ChIP-Seq) data, contributes to ProPhase's commitment to advancing genetic diagnostics for various health concerns.

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chromatin immunoprecipitation (chip) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chromatin immunoprecipitation (ChIP) sequencing market consists of revenues earned by entities by providing services such as ChIP sample preparation, library preparation and sequencing, bioinformatics analysis, customization and consultation, data interpretation and reporting, and quality control, and assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The ChIP sequencing market also includes sales of ChIP kits, antibodies, DNA library preparation kits, sequencing kits, chromatin shearing equipment, and epigenetic modification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chromatin immunoprecipitation (ChIP) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chromatin immunoprecipitation (Chip) sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chromatin immunoprecipitation (chip) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: DNase-Sequencing; FAIRE-Sequencing
  • 2) By Technology: Targeted Sequencing And Re-Sequencing; Whole Genome Sequencing And Whole Exome Sequencing
  • 3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
  • 4) By Application: Consumables And Reagents; Service; Other Applications
  • 5) By End-User: Academic Research Institutes; Clinical Research Institutes; Hospitals And Clinics; Pharmaceuticals And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific Inc. ; Becton Dickinson and Co.; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Characteristics

3. Chromatin Immunoprecipitation (ChIP) Sequencing Market Trends And Strategies

4. Chromatin Immunoprecipitation (ChIP) Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Size and Growth

  • 5.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chromatin Immunoprecipitation (ChIP) Sequencing Market Segmentation

  • 6.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • DNase-Sequencing
  • FAIRE-Sequencing
  • 6.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Targeted Sequencing And Re-Sequencing
  • Whole Genome Sequencing And Whole Exome Sequencing
  • 6.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pre-Sequencing
  • Sequencing
  • Data Analysis
  • 6.4. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables And Reagents
  • Service
  • Other Applications
  • 6.5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Clinical Research Institutes
  • Hospitals And Clinics
  • Pharmaceuticals And Biotechnology Companies
  • Other End Users

7. Chromatin Immunoprecipitation (ChIP) Sequencing Market Regional And Country Analysis

  • 7.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 8.1. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 9.1. China Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 9.2. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 10.1. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 11.1. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 11.2. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 12.1. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 13.1. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 14.1. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 14.2. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 15.1. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 15.2. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 16.1. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 17.1. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 18.5. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 19.9. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 20.13. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 21.1. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 21.2. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 22.1. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 23.1. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 23.2. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 24.1. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 24.2. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 25.1. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 25.2. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 26.1. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 26.2. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 27.1. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 28.1. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 28.2. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 29.1. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 29.2. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape
  • 30.2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Co.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chromatin Immunoprecipitation (ChIP) Sequencing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Qiagen N.V.
  • 31.6. Bio-Techne Corp.
  • 31.7. BGI Genomics Co. Ltd.
  • 31.8. Promega Corporation
  • 31.9. GenScript Biotech Corporation
  • 31.10. Abcam plc
  • 31.11. BioLegend Inc.
  • 31.12. Hamilton Co.
  • 31.13. Takara Bio Inc.
  • 31.14. Novogene Co. Ltd.
  • 31.15. Oxford Nanopore Technologies plc

32. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Benchmarking

33. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chromatin Immunoprecipitation (ChIP) Sequencing Market

35. Chromatin Immunoprecipitation (ChIP) Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer